Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03371745 · ClinicalTrials.gov registry record · NA

The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

A NA study, sponsored by Yale University.

Terminated
Registry status
NA
Development phase
32
Enrollment target

NCT03371745 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03371745, a NA study, was terminated before completion, sponsored by Yale University.

TERMINATED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The trial objective is to determine whether the deferred transfer of embryos following cryopreservation at the blastocyst stage following pre-implantation genetic screening (PGS-FET) improves live birthrates compared to both the deferred transfer of cryopreserved embryos without PGS (FET) and immediate transfer at the conclusion of a "fresh" in vitro fertilization (IVF) cycle (Fresh). Additionally, whether "freeze-only" (FET) improves live birth rates compared to "fresh" will be determined.

Interventions

  • PROCEDURE Trophectoderm biopsy
  • PROCEDURE Cryopreservation
  • PROCEDURE Embryo Transfer

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-08-21
Est. Completion 2019-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03371745

The ClinicalTrials.gov registry entry for NCT03371745 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Trophectoderm biopsy is the first listed.

NCT03371745 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03371745 about?

NCT03371745 is a clinical study titled "The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)". The trial objective is to determine whether the deferred transfer of embryos following cryopreservation at the blastocyst stage following pre-implantation genetic screening (PGS-FET) improves live birthrates compared to both the deferred transfer of cryopreserved embryos without PGS (FET) and immedi...

What is the current status of trial NCT03371745?

This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2018-08-21. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03371745?

The interventions under investigation include: Trophectoderm biopsy (PROCEDURE), Cryopreservation (PROCEDURE), Embryo Transfer (PROCEDURE).

Who is sponsoring clinical trial NCT03371745?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.